BioIVT to highlight its integral role in liquid biopsy research at AACC conference

Shorla raised $35m earlier this month to advance its oncology pipeline. Credit: zorazhuang via Getty Images. Shorla Oncology has acquired the oncology and autoimmune drug

Af­fimed is slash­ing its head­count by up to half as part of a broad­er re­or­ga­ni­za­tion aimed at sup­port­ing the com­pa­ny through its next round of

Te­va is tak­ing Alvotech’s man­u­fac­tur­ing trou­bles in­to its own hands af­ter de­fi­cien­cies at an Ice­landic fa­cil­i­ty led to an­oth­er re­jec­tion for the part­ners’ Hu­mi­ra biosim­i­lar